Key result
Use of the right gastroepiploic artery as a coronary artery bypass graft demonstrated an in-hospital mortality of 1.6% and a mid-term angiographic patency rate of 91.8%.
Why the study?
Does the use of the right gastroepiploic artery as a coronary artery bypass graft provide acceptable clinical outcomes and patency in patients undergoing coronary surgery?
Observational (n=307)
Does the use of the right gastroepiploic artery as a coronary artery bypass graft provide acceptable clinical outcomes and patency in patients undergoing coronary surgery?
The right gastroepiploic artery can be safely used as a coronary artery bypass graft with low mortality, low morbidity, and high mid-term patency rates.
Answers are grounded in this paper and cite their sources.
Supports right gastroepiploic artery as bypass conduit option; leaves open need for randomized trials versus standard arterial grafts.
From October 1988 to October 1995 the right gastroepiploic artery was used as a conduit for coronary surgery in 307 patients. Their average age was 56.5 years (range 25-75) and 274 patients (89%) were male. Twenty-six cases (8.5%) were re-operations and 58 patients (19%) were operated upon on an urgent or semi-urgent basis. Target coronary vessels were the right coronary artery and its branches in 280 cases (91.4%), the circumflex artery in 25 cases (8%) and the left anterior descending artery in two cases. The right gastroepiploic artery was used as an in situ graft in 303 cases (98.7%) and as a free graft in 4 (1.3%). A total of 291 patients (94.8%) also received at least one mammary artery graft: both mammary arteries were used in 167 patients (54.4%). An average of 3.6 distal anastomoses were made per patient, three of them with arterial grafts. Eleven (3.2%) right gastroepiploic artery grafts were doubled with saphenous vein intraoperatively because of persistent myocardial ischemia. In-hospital mortality was 1.6% (five patients). Perioperative myocardial infarction occurred in twelve patients (3.9%). Follow-up now averages 26 months (range 6-88). There have been five late deaths (1.6%). A total of 265 (89.2%) patients are angina free. Of the total, 145 patients have been investigated with a maximal-stress test coupled with scintigraphy: residual myocardial ischemia was found in 10 patients, right gastroepiploic artery was related in three. Ninety-six patients have undergone angiographic restudy at a mean of 12 months (range 8-88) postoperatively. Patency of the right gastroepiploic artery grafts was 91.8%. This study confirms that the right gastroepiploic artery can be used as a conduit for coronary artery bypass surgery with minimal mortality or morbidity. Mid-term patency rates and clinical outcome are encouraging.
No takes yet. Share an insight, caveat, or question.
Alberto Albertini (1998) conducted an observational in Coronary artery disease requiring bypass surgery (n=307). Right gastroepiploic artery graft was evaluated on In-hospital mortality. Use of the right gastroepiploic artery as a coronary artery bypass graft demonstrated an in-hospital mortality of 1.6% and a mid-term angiographic patency rate of 91.8%.
Synapse has enriched 10 related papers. Consider them for comparative context: